Investigator
Jian Zhang
Z BIOTECH, LLC · funded by NIGMS, NIBIB
- Companies
- 1
- Grants
- 6
- Non-dilutive funding
- $1.6M
- First award
- Apr 1, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Z BIOTECH, LLC51momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R43
Development of TACA Glycan Library and Related Glycomics Products
$314kSep 1, 2025NIGMSZ BIOTECH, LLCNIH RePORTER · 11252818 (opens the source filing in a new tab)
- R43
Development and Commercialization of Sialoglycan-Recognizing Probes
$307kSep 1, 2025NIGMSZ BIOTECH, LLCNIH RePORTER · 11183088 (opens the source filing in a new tab)
- R35
Investigating the mechanobiology of multicellular morphogenesis
$365kSep 1, 2025NIGMSUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11022210 (opens the source filing in a new tab)
- R35
Investigating the mechanobiology of multicellular morphogenesis
$365kSep 1, 2025NIGMSUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11384280 (opens the source filing in a new tab)
- R21
Sorting and characterization of mechanically heterogeneous cell populations based on cellular contractility
$182kAug 1, 2023NIBIBUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11140434 (opens the source filing in a new tab)
- P20
Investigating the bioenergetics of tumor cell clustering and cell-cell interactions
$88kApr 1, 2021NIGMSUNIVERSITY OF ARKANSAS AT FAYETTEVILLENIH RePORTER · 11137554 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources